Logo

UVV

Universal Corporation

UVV

Universal Corporation NYSE
$52.76 0.29% (+0.15)

Market Cap $1.31 B
52w High $67.33
52w Low $49.40
Dividend Yield 3.26%
P/E 11.88
Volume 104.29K
Outstanding Shares 24.92M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2026 $754.177M $72.181M $34.169M 4.531% $1.36 $81.459M
Q1-2026 $593.762M $80.022M $8.497M 1.431% $0.34 $52.443M
Q4-2025 $702.279M $72.142M $9.338M 1.33% $0.37 $55.646M
Q3-2025 $937.193M $89.512M $59.639M 6.364% $2.39 $118.742M
Q2-2025 $710.762M $74.409M $25.94M 3.65% $1.04 $83.131M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2026 $88.652M $3.07B $1.566B $1.47B
Q1-2026 $178.435M $3.189B $1.69B $1.459B
Q4-2025 $260.115M $2.99B $1.489B $1.459B
Q3-2025 $215.108M $3.04B $1.549B $1.451B
Q2-2025 $80.118M $3.046B $1.588B $1.421B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2026 $40.673M $32.745M $-8.308M $-114.057M $-89.783M $23.699M
Q1-2026 $8.497M $-205.103M $-11.91M $134.622M $-81.68M $-217.156M
Q4-2025 $9.338M $158.746M $-5.968M $-108.067M $45.007M $151.03M
Q3-2025 $67.796M $215.641M $-15.466M $-64.457M $134.99M $199.552M
Q2-2025 $33.969M $15.031M $-15.502M $-21.465M $-21.582M $-1.016M

Revenue by Products

Product Q3-2025Q4-2025Q1-2026Q2-2026
Food Ingredient Sales
Food Ingredient Sales
$80.00M $90.00M $80.00M $90.00M
Product and Service Other
Product and Service Other
$20.00M $20.00M $20.00M $10.00M
Service Other
Service Other
$20.00M $20.00M $30.00M $20.00M
Tobacco Sales
Tobacco Sales
$810.00M $560.00M $460.00M $620.00M

Five-Year Company Overview

Income Statement

Income Statement Over the past several years, Universal has grown its sales at a steady, moderate pace. Profit at the operating level has also trended upward, which suggests the core business is being managed more efficiently over time. However, bottom‑line profit and earnings per share have not kept pace with the growth in sales. Recent results show higher revenue but slightly softer earnings per share, pointing to pressure from costs, interest, or mix. Overall, it looks like a mature, relatively stable income statement with modest growth and limited margin expansion, rather than a high‑growth story.


Balance Sheet

Balance Sheet The balance sheet shows a company that has grown gradually while leaning more on debt. Total assets and shareholders’ equity have edged up over time, indicating ongoing investment and a still‑solid capital base. At the same time, borrowings have increased noticeably compared with a few years ago, which means leverage is higher and interest costs matter more. Cash levels dipped to very lean levels for a while and then recovered more recently, so liquidity looks better now but has been tight at points. In short, the balance sheet is serviceable but clearly more debt‑dependent than before.


Cash Flow

Cash Flow Cash generation has been uneven. A few years back, operating cash flow and free cash flow were weak and even negative at times, despite the company reporting profits. That likely reflects swings in working capital tied to inventory and receivables in a seasonal, commodity‑linked business. More recently, cash flow has rebounded to healthier levels, with free cash flow again comfortably positive after routine investment spending. Capital spending itself has been relatively steady and not excessive. The main watchpoint is consistency: cash flow does not always track accounting earnings, so timing and working capital management are key risks.


Competitive Edge

Competitive Edge Universal holds a strong, entrenched position in the global leaf tobacco supply chain, operating essentially in a duopoly with one primary rival. Deep, long‑running relationships with major tobacco manufacturers, plus global farmer networks and logistics know‑how, give it a durable edge and create high barriers to entry. Its proprietary farm‑to‑factory data systems and traceability tools reinforce this advantage. On the other hand, the underlying tobacco market is slowly shrinking and heavily regulated, which caps long‑term growth and adds political and social risk. The newer plant‑based ingredients platform offers diversification into a healthier, growing category but faces a more crowded and dynamic competitive field.


Innovation and R&D

Innovation and R&D Innovation is focused less on breakthrough science and more on process, data, and application. In tobacco, the MobiLeaf platform and agronomy centers help improve yields, traceability, and sustainability, strengthening ties with both farmers and global customers. In ingredients, the company has invested in advanced extraction and aseptic processing capabilities, especially at its Shank’s facility, positioning it to supply high‑value, clean‑label flavors and plant‑based ingredients. Acquisitions like FruitSmart, Silva, and Shank’s have effectively bought in specialized R&D and product development capabilities. The key opportunity is to turn these assets into a tightly integrated, differentiated ingredients platform; the key risk is execution and keeping innovation aligned with fast‑changing food and beverage trends.


Summary

Universal looks like a classic mature cash‑generating business in transition. The legacy tobacco operations provide scale, relationships, and relatively steady earnings, but they sit in a structurally challenged, slow‑decline industry with rising regulatory and ESG scrutiny. Financially, revenue and operating profit have grown modestly, while net income has been flatter, leverage has gradually increased, and cash flow has been somewhat volatile but recently improving. Strategically, management is using the stability of the tobacco business to build a second pillar in plant‑based ingredients, backed by targeted acquisitions, process innovation, and sustainability initiatives. The long‑term story hinges on how successfully the company can grow and integrate this newer segment while maintaining discipline around debt levels and cash generation from its legacy core.